Many Blue Cross Blue Shield plans aren’t paying taxes; tracking an FDA meeting on Covid vaccines in young children

STAT reviewed the financial statements of 32 BCBS insurers. A dozen have collectively claimed billions in tax refunds. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: Many Blue Cross Blue Shield plans aren't paying taxes — and instead are swimming in refunds By Bob Herman Adobe STAT reviewed the financial statements of 32 BCBS insurers. A dozen have collectively claimed billions in tax refunds. Read More Tracking an FDA advisory panel meeting on Covid vaccines in young children By Helen Branswell and Matthew Herper Joe Raedle/Getty Images STAT will be live-blogging the all-day meeting of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC. Read More STAT+: Third Rock Ventures plots next chapter after raising $1.1 billion fund By Allison DeAngelis Third Rock Ventures STAT spoke with Third Rock partners Abbie Celniker and Reid Huber about their plans for investing their sixth and largest fund. Read More Sponsor content by RBC Capital Markets Spotlight on healthcare innovation and M&A Disruptive technology remains vital to the future of healthcare. "If you think about what's happening in AI and machine-learning drug discovery: those are exciting places to be," says Andrew Callaway, RBC's Global Head, Healthcare Investment Banking. Learn how wearables and digital therapeutics are emerging as important licensing opportunities today, but could be focal points for M&A tomorrow. Hear from RBC's experts. STAT+: Supreme Court sides with hospitals on Medicare drug pay dispute By Rachel Cohrs Jon Elswick/AP The Supreme Court sided with hospitals in a legal dispute over the Trump administration’s Medicare pay cuts for discounted drugs. Read More Popular drug may have new benefit in men with diabetes, but not women, study shows By Akila Muthukumar Adobe Only one previous randomized study of the heart benefits for diabetic patients from erectile dysfunction drugs enrolled both men and women. Read More STAT+: In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries By Ed Silverman Janice Carr/CDC via AP "Lt’s try to reduce the gap to less than three years in which all countries can access the drug," said Jennifer Cohen of GARD-P. Read More STAT+: FDA oversight of pharma manufacturing facilities plunges during the pandemic By Ed Silverman Sarah Silbiger/Getty Images A new FDA report finds that agency oversight of pharmaceutical manufacturing facilities plunged during the pandemic. Read More Opinion: Youth and gender-affirming care: let's start with 'do no harm' By Julie Morita and Donald Schwartz Julie Bennett/Getty Images To help youths questioning their gender, listen intently, use gender-affirming care, and don't turn to conversion therapy. Read More Wednesday, June 15, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser